Latest filing published 02 Nov 2026 for Bambusa Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Salvia Investment GmbH: trading record in brief
Salvia Investment GmbH appears in our data through filings on Bambusa Therapeutics, Inc. shares, published by SEC (Form 4). Altogether 2 filings, all relating to 2 November 2026.
The open-market record is one-sided, with 1 purchase worth €5.4M and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
On 2 November 2026 came the latest disclosure, a transaction in Bambusa Therapeutics, Inc. The clock since the last published purchase (2 November 2026) now reads 7 days. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Salvia Investment GmbH
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,769,701 sharesCommon StockSEC:0002162499-26-000004:0
- 375,000 shares@ US$16.00100.0% of flowCommon StockSEC:0002162499-26-000004:1Canonical exit: 31 Jan 2027 (T+90)
2 of 2 declarations